Article
Production of a human iPSC line from an early-onset Parkinson's disease patient with a novel CHCHD2 gene truncated mutation.
Stem cell research - 1 Oct 2022
Jiang Zheng, Gu Xiao-Jing, Su Wei-Ming, Duan Qing-Qing, Lin Jun-Yu, Cao Bei, Shang Hui-Fang, Chen Yong-Ping
Abstract excerpt
CHCHD2 mutations have been reported to cause Parkinson's disease (PD) by a loss of function in mitochondria. Most reported mutations, however, were missense, which was not the perfect model for a study of haploinsufficiency. Here, a truncated mutation, CHCHD2 p.Pro53Alafs*38, was identified in one familial early-onset PD patient. We generated a human-induced pluripotent stem cell (iPSC) line WCHSCUi001-A from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
